8 December 2021 - interim results

We reduced our recommendation on the shares of this AIM-listed supplier to HOLD some time ago as we thought the share price had got ahead of itself.  Today's announcement of the interim results for the six months to the end of September has justified that stance with the results coming in below management expectations.  Sales for the period fell to £3.2m (2020: £6.7m) although last year benefited from extremely strong trade due to COVID-19 as the company's anti-bacterial products were in high demand.  As a result the group . . .

This content is restricted to members only. We offer three packages from 1 month to a whole year of daily tips, market news and commentary, plus our monthly newsletters.
Registration is quick and simple HERE.

Already a member, log in HERE.